Accelerate to discover

Back to filter

Related topics

Genotype-targeted local therapy of glioma

Spectral Instruments Imaging

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

IncuCyte webinar: Organoids, iPSCs, and advanced cell models.

Sartorius

Mar 24, 2020

Researchers are now moving from reductionist, 2D monoculture assay models to more complex 3D cell models, such as...

Cytek spectral cytometers: 21 color panels with just 2 lasers

Cytek Biosciences

Mar 23, 2020

Until recently, developing multicolor fluorescence-based flow cytometry assays on a two laser system has been limited...

Cancer cells resist mechanical destruction in the circulation via RhoA-myosin II axis

Spectral Instruments Imaging

Mar 20, 2020

Tumors may generate millions of Circulating tumor cells per day, but seminal work in cancer biology has established the...

Mar 28, 2020

IncuCyte live cell analysis system for 3D Organoids discovery

Sartorius

Mar 18, 2020

Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...

Webinar recording: Ex vivo microangioCT, advances in microvascular imaging

Bruker Biospin

Mar 16, 2020

A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...

Single Cell Sequencing sample preparation without centrifugation

Curiox

Mar 10, 2020

Single-cell genomics is rapidly growing. Nature Methods named multimodal omics the method of the year for 2019. And as...

Mar 28, 2020

Comparing image quality in Phase Contrast X-Ray Tomography

Bruker Biospin

Feb 28, 2020

How to evaluate and compare image quality from different submicrometer CT scans? A simple yet clever test phantom is...

Show all topics (10)

Applications of Bionano Next-Generation Mapping (NGM) method to cancer patients–NGS is not enough

Feb 9, 2017

Thursday, February 23, 2017, 10 pm CET.

In this webinar, Professor Vanessa Hayes of the Garvan Institute of Medical Research reports the first complete tumor-normal map from a primary prostate cancer. Her team identified 85 large somatic deletion and insertion rearrangements, of which half directly impact genes or gene regions. However, only one-tenth of these large structural variations were detectable using high-coverage, short-read NGS and automated five-tooled bioinformatic analyses. This webinar will highlight how Bionano NGM closes the gap on what is missing from NGS.

Register now

Application
Webinar

Related technologies: Genome mapping

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

BioNano Genomics

A revolutionary NanoChannel technology for Genome mapping of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias.

Related products

Genome maps of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey